Shanghai-based cell therapy developer Neukio Biotherapeutics has raised USD 50m in the first tranche of a Series A round led by medical technology-focused CD Capital. Other new investors include Alwin Capital and Surplus Capital.
Existing shareholders Lilly Asia Ventures, Sherpa Healthcare Partners, and IDG Capital re-upped. AVCJ Research's records show they provided USD 40m in angel funding in July 2021. The fresh proceeds will...
Asian private equity has moved on from chasing momentum plays, with GPs increasingly pursuing opportunities where they have domain expertise and know they can add value, the AVCJ Private Equity & Venture Forum heard.
An emerging technology giant has imploded. Regulations are set to tighten. Investors hit pause but remain confident about the long-term outlook. Business as usual in crypto
Patrick Reid, a UK-based managing director for alternatives distribution management at Morgan Stanley, plots the future of themes around secondaries, longer holds, and hybrid approaches to PE
LionRock Capital is exiting Clarks to its majority partner, Li Ning-owned and Hong Kong-listed Viva China, having helped the struggling British shoe brand survive the pandemic